Kewaunee Scientific Corporation
KEQU
$34.88
$0.320.93%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.44% | -7.18% | -7.71% | -7.17% | -6.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.44% | -7.18% | -7.71% | -7.17% | -6.59% |
| Cost of Revenue | 4.76% | -13.30% | -15.86% | -17.51% | -15.17% |
| Gross Profit | 24.46% | 15.27% | 27.40% | 46.26% | 38.25% |
| SG&A Expenses | 49.89% | 26.54% | 24.79% | 25.26% | 9.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.66% | -6.91% | -9.69% | -11.46% | -11.65% |
| Operating Income | -29.59% | -11.07% | 36.16% | 166.47% | 207.65% |
| Income Before Tax | -36.26% | -11.20% | 47.12% | 191.66% | 211.75% |
| Income Tax Expenses | -272.43% | -251.74% | -281.65% | -289.17% | 11.74% |
| Earnings from Continuing Operations | 98.56% | 151.63% | 308.88% | 1,302.28% | 14,341.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 2.50% | 64.01% | 51.42% | 51.05% | 57.60% |
| Net Income | 101.34% | 170.38% | 366.58% | 2,441.06% | 1,488.24% |
| EBIT | -29.59% | -11.07% | 36.16% | 166.47% | 207.65% |
| EBITDA | -19.37% | -7.13% | 30.71% | 111.14% | 135.19% |
| EPS Basic | 102.68% | 170.88% | 363.42% | 2,427.22% | 1,440.67% |
| Normalized Basic EPS | -36.90% | -6.99% | 58.65% | 253.96% | 267.01% |
| EPS Diluted | 98.59% | 165.61% | 359.73% | 2,727.17% | 1,336.28% |
| Normalized Diluted EPS | -38.20% | -8.56% | 58.14% | 260.03% | 264.80% |
| Average Basic Shares Outstanding | -0.30% | 0.43% | 1.35% | 1.92% | 2.03% |
| Average Diluted Shares Outstanding | 1.70% | 1.91% | 2.43% | 2.41% | 3.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |